Arvinas (ARVN) Share-based Compensation Growth (3y) (2020 - 2026)
Arvinas (ARVN) Share-based Compensation Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.80% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-15.28% |
| Date | Value |
|---|
| Mar 31, 2026 |
-15.28% |
| Dec 31, 2025 |
-24.94% |
| Sep 30, 2025 |
-18.44% |
| Jun 30, 2025 |
-19.84% |
| Mar 31, 2025 |
-3.32% |
| Dec 31, 2024 |
11.08% |
| Sep 30, 2024 |
17.50% |
| Jun 30, 2024 |
13.95% |
| Mar 31, 2024 |
21.78% |
| Dec 31, 2023 |
27.39% |
| Sep 30, 2023 |
26.51% |
| Jun 30, 2023 |
33.13% |
| Mar 31, 2023 |
48.15% |
| Dec 31, 2022 |
58.91% |
| Sep 30, 2022 |
59.87% |
| Jun 30, 2022 |
55.56% |
| Mar 31, 2022 |
47.46% |
| Dec 31, 2021 |
46.19% |
| Sep 30, 2021 |
61.30% |
| Jun 30, 2021 |
146.07% |
